{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:45:13Z","timestamp":1787589913121,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022AJT27Y"],"award-info":[{"award-number":["PRIN 2022AJT27Y"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012306","name":"Universit\u00e0 degli Studi di Trieste","doi-asserted-by":"publisher","award":["CUP J53D23002030006"],"award-info":[{"award-number":["CUP J53D23002030006"]}],"id":[{"id":"10.13039\/501100012306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijcard.2026.134175","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:21:08Z","timestamp":1768234868000},"page":"134175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibition"],"prefix":"10.1016","volume":"448","author":[{"given":"Chiara","family":"Zocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Milazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Panichella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela I.","family":"Fanizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Ragagnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Coppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Pedrizzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Del Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcard.2026.134175_bb0005","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and Management of Hypertrophic Cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2026.134175_bb0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0003-4975(02)04546-0","article-title":"Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction","volume":"75","author":"Sherrid","year":"2003","journal-title":"Ann. Thorac. Surg."},{"issue":"10253","key":"10.1016\/j.ijcard.2026.134175_bb0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijcard.2026.134175_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ehjci\/jev137","article-title":"Changes in electrical activation modify the orientation of left ventricular flow momentum: novel observations using echocardiographic particle image velocimetry","volume":"17","author":"Pedrizzetti","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"95","key":"10.1016\/j.ijcard.2026.134175_bb0025","article-title":"On the computation of hemodynamic forces in the heart chambers","volume":"11","author":"Pedrizzetti","year":"2019","journal-title":"J. Biomech."},{"issue":"5","key":"10.1016\/j.ijcard.2026.134175_bb0030","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/ehf2.14346","article-title":"Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril\/valsartan","volume":"10","author":"Fabiani","year":"2023","journal-title":"ESC Heart Failure."},{"issue":"1","key":"10.1016\/j.ijcard.2026.134175_bb0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/ehf2.13719","article-title":"Impact of intraventricular haemodynamic forces misalignment on left ventricular remodelling after myocardial infarction","volume":"9","author":"Filomena","year":"2021","journal-title":"ESC Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134175_bb0040","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/jcm12031218","article-title":"Acute modification of hemodynamic forces in patients with severe aortic stenosis after transcatheter aortic valve implantation","volume":"12","author":"Vairo","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2026.134175_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fcvm.2019.00059","article-title":"Left ventricular response to cardiac resynchronization therapy: insights from hemodynamic forces computed by speckle tracking","volume":"6","author":"Dal Ferro","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2026.134175_bb0050","article-title":"Assessing cardiac mechanics through left ventricular haemodynamic forces","volume":"1;2(3):qyae077","author":"Aimo","year":"2024","journal-title":"European Heart Journal - Imaging Methods and Practice."},{"issue":"37","key":"10.1016\/j.ijcard.2026.134175_bb0055","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134175_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011188","article-title":"Long-term effects of Mavacamten on electromechanical dispersion and deformation in obstructive hypertrophic cardiomyopathy","volume":"17","author":"Del Franco","year":"2024","journal-title":"Circ. Heart Fail."},{"issue":"10","key":"10.1016\/j.ijcard.2026.134175_bb0065","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","article-title":"Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy","volume":"141","author":"Toepfer","year":"2020","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ijcard.2026.134175_bb0070","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.jacc.2020.03.064","article-title":"Evaluation of Mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy","volume":"75","author":"Ho","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2026.134175_bb0075","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cardfail.2024.02.020","article-title":"Efficacy and safety of Aficamten in symptomatic nonobstructive hypertrophic cardiomyopathy: results from the REDWOOD-HCM trial, cohort 4","volume":"30","author":"Masri","year":"2024","journal-title":"J. Card. Fail."},{"issue":"45","key":"10.1016\/j.ijcard.2026.134175_bb0080","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehz326","article-title":"Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients","volume":"40","author":"Wu","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134175_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-8703(87)90701-0","article-title":"An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observations","volume":"113","author":"Jiang","year":"1987","journal-title":"Am. Heart J."},{"issue":"19","key":"10.1016\/j.ijcard.2026.134175_bb0090","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jacc.2014.04.090","article-title":"Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve","volume":"64","author":"Ro","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2026.134175_bb0095","first-page":"795","article-title":"Electrophysiological and contractile effects of disopyramide in patients with obstructive hypertrophic cardiomyopathy. JACC: basic to translational","volume":"4","author":"Coppini","year":"2019","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ijcard.2026.134175_bb0100","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/01.CIR.90.6.2731","article-title":"Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy","volume":"90","author":"Fananapazir","year":"1994","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijcard.2026.134175_bb0105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa2504654","article-title":"Aficamten or metoprolol monotherapy for obstructive hypertrophic cardiomyopathy","volume":"393","author":"Garcia-Pavia","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134175_bb0110","doi-asserted-by":"crossref","unstructured":"Nag S, Gollapudi SK, del Rio CL, Spudich JA, McDowell R. Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients. Sci. Adv. 9(30):eabo7622.","DOI":"10.1126\/sciadv.abo7622"},{"issue":"Supplement_1","key":"10.1016\/j.ijcard.2026.134175_bb0115","article-title":"Effect of Mavacamten on left ventricular diastolic function and left atrial function in obstructive hypertrophic cardiomyopathy","volume":"46","author":"Cohen","year":"2025","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.ijcard.2026.134175_bb0120","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2021.09.1381","article-title":"Effect of Mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Hegde","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134175_bb0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/CIRCRESAHA.110.223842","article-title":"Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor","volume":"111","author":"Moore","year":"2012","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ijcard.2026.134175_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017185","article-title":"Serial changes in ventricular strain in symptomatic obstructive hypertrophic cardiomyopathy treated with Mavacamten: insights from the VALOR-HCM trial","volume":"17","author":"Desai","year":"2024","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"8","key":"10.1016\/j.ijcard.2026.134175_bb0135","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.echo.2024.05.002","article-title":"Mitral geometry on the mechanism of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"37","author":"Lin","year":"2024","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"273","key":"10.1016\/j.ijcard.2026.134175_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2018.09.004","article-title":"Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy","volume":"15","author":"Cavigli","year":"2018","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T20:47:08Z","timestamp":1769892428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":28,"alternative-id":["S0167527326000239"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134175","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibition","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"134175"}}